Pharma Privat GmbH, a prominent player in the pharmaceutical industry, is headquartered in Germany and operates extensively across Europe. Founded in 2005, the company has established itself as a leader in the development and distribution of high-quality generic medications and innovative healthcare solutions. With a focus on prescription drugs, over-the-counter products, and specialised therapies, Pharma Privat GmbH is committed to enhancing patient care through its unique offerings. The company’s dedication to quality and compliance has earned it a strong market position, recognised for its reliability and efficiency in the supply chain. Notable achievements include strategic partnerships and a robust portfolio that caters to diverse therapeutic areas, ensuring that Pharma Privat GmbH remains at the forefront of the pharmaceutical landscape.
How does Pharma Privat GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Pharma Privat GmbH's score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2021, Pharma Privat GmbH reported total carbon emissions of approximately 1,487,150 kg CO2e. This figure includes Scope 1 emissions of about 27,080 kg CO2e, Scope 2 emissions of approximately 97,560 kg CO2e, and significant Scope 3 emissions totalling around 1,416,510 kg CO2e. The Scope 3 emissions breakdown reveals key contributors: business travel accounted for about 62,000 kg CO2e, employee commute for approximately 333,000 kg CO2e, and purchased goods and services for around 1,007,000 kg CO2e. Despite the substantial emissions reported, Pharma Privat GmbH has not disclosed any specific reduction targets or climate pledges. The absence of formal commitments suggests a need for enhanced climate strategies within the organisation. As of now, there are no emissions data cascaded from a parent or related organisation, indicating that the reported figures are solely from Pharma Privat GmbH's own operations. Overall, while the company has made strides in emissions reporting, it appears to lack defined climate commitments or reduction initiatives, which are critical for aligning with industry standards and addressing climate change effectively.
Access structured emissions data, company-specific emission factors, and source documents
2021 | |
---|---|
Scope 1 | 27,080 |
Scope 2 | 97,560 |
Scope 3 | 1,416,510 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharma Privat GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.